Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Marks

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Journal of the Society for Gynecologic Investigation|May 5, 2001
Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormonesL J Havrilesky, C P McMahon, E K Lobenhofer, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 1, 1994
Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cellsA Elbendary, A Berchuck, P Davis, et al.
Cancer Research|October 15, 1990
Increased erbB-2 gene copies and expression in multiple stages of breast cancerJ D Iglehart, M H Kraus, B C Langton, et al.
Obstetrics and Gynecology|May 1, 1993
Mutation and overexpression of p53 in early-stage epithelial ovarian cancerM F Kohler, B J Kerns, P A Humphrey, et al.
The Journal of Surgical Research|August 29, 2003
Dhh1 regulates the G1/S-checkpoint following DNA damage or BRCA1 expression in yeastT J Westmoreland, J A Olson, W Y Saito, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 1, 1993
Assessment of c-erbB-2 amplification by immunohistochemistry in paraffin-embedded breast cancerB J Kerns, P A Jordan, G Huper, et al.
Eye (London, England)|April 14, 2012
Agreement between specially trained and accredited optometrists and glaucoma specialist consultant ophthalmologists in their management of glaucoma patientsJ R Marks, A K Harding, R A Harper, et al.
British Journal of Cancer|July 17, 1999
Bcl10 is not a target for frequent mutation in human carcinomasA R Lambers, C Gumbs, S Ali, et al.
Annals of Surgery|April 1, 1994
Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancerJ R Marks, P A Humphrey, K Wu, et al.
Anticancer Research|August 26, 1998
Complex response of breast epithelial cell lines to topoisomerase inhibitorsP L Davis, W L Shaiu, G L Scott, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Journal of the Society for Gynecologic Investigation|May 5, 2001
Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormonesL J Havrilesky, C P McMahon, E K Lobenhofer, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 1, 1994
Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cellsA Elbendary, A Berchuck, P Davis, et al.
Cancer Research|October 15, 1990
Increased erbB-2 gene copies and expression in multiple stages of breast cancerJ D Iglehart, M H Kraus, B C Langton, et al.
Obstetrics and Gynecology|May 1, 1993
Mutation and overexpression of p53 in early-stage epithelial ovarian cancerM F Kohler, B J Kerns, P A Humphrey, et al.
The Journal of Surgical Research|August 29, 2003
Dhh1 regulates the G1/S-checkpoint following DNA damage or BRCA1 expression in yeastT J Westmoreland, J A Olson, W Y Saito, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 1, 1993
Assessment of c-erbB-2 amplification by immunohistochemistry in paraffin-embedded breast cancerB J Kerns, P A Jordan, G Huper, et al.
Eye (London, England)|April 14, 2012
Agreement between specially trained and accredited optometrists and glaucoma specialist consultant ophthalmologists in their management of glaucoma patientsJ R Marks, A K Harding, R A Harper, et al.
British Journal of Cancer|July 17, 1999
Bcl10 is not a target for frequent mutation in human carcinomasA R Lambers, C Gumbs, S Ali, et al.
Annals of Surgery|April 1, 1994
Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancerJ R Marks, P A Humphrey, K Wu, et al.
Anticancer Research|August 26, 1998
Complex response of breast epithelial cell lines to topoisomerase inhibitorsP L Davis, W L Shaiu, G L Scott, et al.
Pageof 8